Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Miltenyi Biotec, Nexell, Becton, Dickinson and Co., Johns Hopkins University gene/cell therapy news

NEXL said it, the university and Becton filed a patent infringement and breach

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE